Latest Insider Transactions at Alignment Healthcare, Inc. (ALHC)
This section provides a real-time view of insider transactions for Alignment Healthcare, Inc. (ALHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alignment Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alignment Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
666
-0.16%
|
$5,328
$8.0 P/Share
|
|
Jun 14
2024
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.29%
|
$9,600
$8.06 P/Share
|
|
Jun 14
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
16,000
-3.65%
|
$128,000
$8.01 P/Share
|
|
Jun 12
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,000
-1.01%
|
$160,000
$8.21 P/Share
|
|
Mar 28
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,363
-1.0%
|
$17,452
$4.84 P/Share
|
|
Mar 28
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,299
-0.49%
|
$17,196
$4.84 P/Share
|
|
Mar 28
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
10,151
-0.51%
|
$40,604
$4.84 P/Share
|
|
Mar 28
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
1,821
-0.42%
|
$7,284
$4.84 P/Share
|
|
Mar 20
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
13,252
-0.66%
|
$53,008
$4.83 P/Share
|
|
Mar 19
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,522
-3.18%
|
$142,610
$5.05 P/Share
|
|
Mar 19
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
18,964
-4.18%
|
$94,820
$5.05 P/Share
|
|
Mar 19
2024
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,576
-0.99%
|
$27,880
$5.05 P/Share
|
|
Mar 19
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
25,060
-5.4%
|
$125,300
$5.05 P/Share
|
|
Mar 19
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,078
-0.7%
|
$15,390
$5.05 P/Share
|
|
Mar 19
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
15,861
-0.79%
|
$79,305
$5.05 P/Share
|
|
Mar 15
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,326
-0.94%
|
$17,304
$4.89 P/Share
|
|
Mar 15
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,858
-1.3%
|
$47,432
$4.89 P/Share
|
|
Mar 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
21,537
-1.06%
|
$86,148
$4.89 P/Share
|
|
Mar 15
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,852
-1.09%
|
$19,408
$4.89 P/Share
|
|
Mar 14
2024
|
John E Kao Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
103,000
+3.62%
|
$412,000
$4.82 P/Share
|
|
Mar 13
2024
|
General Atlantic LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+0.16%
|
-
|
|
Mar 13
2024
|
General Atlantic (Aln Hlth), L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+0.16%
|
-
|
|
Mar 13
2024
|
Sebastian Burzacchi COO - Mgmt Services Org |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+30.68%
|
-
|
|
Mar 13
2024
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.92%
|
-
|
|
Mar 13
2024
|
Hakan Kardes Chief Experience Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,190
+23.43%
|
-
|
|
Mar 13
2024
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+5.27%
|
-
|
|
Mar 13
2024
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,710
+18.07%
|
-
|
|
Mar 13
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,138
+29.71%
|
-
|
|
Mar 13
2024
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.92%
|
-
|
|
Mar 13
2024
|
Thomas J. Carella Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+24.32%
|
-
|
|
Mar 13
2024
|
Dawn Christine Maroney President, Markets |
BUY
Grant, award, or other acquisition
|
Direct |
206,890
+9.22%
|
-
|
|
Mar 13
2024
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+29.04%
|
-
|
|
Mar 13
2024
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+8.0%
|
-
|
|
Mar 13
2024
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+12.55%
|
-
|
|
Mar 13
2024
|
Andreas P. Wagner Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+21.76%
|
-
|
|
Mar 13
2024
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
330,000
+11.1%
|
-
|
|
Mar 13
2024
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+27.16%
|
-
|
|
Mar 13
2024
|
Robert L. Scavo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+15.19%
|
-
|
|
Mar 13
2024
|
Hyong Kim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158,970
+22.08%
|
-
|
|
Mar 13
2024
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,500
+22.32%
|
-
|
|
Mar 13
2024
|
Jeffrey H Margolis Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+22.31%
|
-
|
|
Mar 08
2024
|
John E Kao Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,520
-1.47%
|
$172,600
$5.39 P/Share
|
|
Mar 08
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
23,000
-1.24%
|
$115,000
$5.44 P/Share
|
|
Mar 06
2024
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
6,000
-0.32%
|
-
|
|
Feb 07
2024
|
Andreas P. Wagner Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,763
+50.0%
|
-
|
|
Dec 21
2023
|
Sebastian Burzacchi COO - Mgmt Services Org |
BUY
Grant, award, or other acquisition
|
Direct |
125,945
+50.0%
|
-
|
|
Dec 14
2023
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.29%
|
$9,600
$8.46 P/Share
|
|
Dec 06
2023
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.29%
|
$9,600
$8.0 P/Share
|
|
Nov 10
2023
|
Joseph S Konowiecki Director |
SELL
Open market or private sale
|
Direct |
4,898
-0.41%
|
$24,490
$5.9 P/Share
|
|
Oct 16
2023
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
6,000
-1.41%
|
$48,000
$8.0 P/Share
|